Your browser doesn't support javascript.
loading
Ramifications of the HLA-I Allelic Reactivity of Anti-HLA-E*01:01 and Anti-HLA-E*01:03 Heavy Chain Monoclonal Antibodies in Comparison with Anti-HLA-I IgG Reactivity in Non-Alloimmunized Males, Melanoma-Vaccine Recipients, and End-Stage Renal Disease Patients.
Ravindranath, Mepur H; Ravindranath, Narendranath M; El Hilali, Fatiha; Selvan, Senthamil R; Filippone, Edward J.
Afiliação
  • Ravindranath MH; Department of Hematology and Oncology, Children's Hospital, Los Angeles, CA 90027, USA.
  • Ravindranath NM; Emeritus Research Scientist at Terasaki Foundation Laboratory, Santa Monica, CA 90064, USA.
  • El Hilali F; Norris Dental Science Center, Herman Vostro School of Dentistry, University of Southern California, Los Angeles, CA 90089, USA.
  • Selvan SR; Faculty of Medicine and Pharmacy of Laayoune, Ibn Zohr University, Agadir 70000, Morocco.
  • Filippone EJ; Tetracore Inc., Rockville, MD 20850, USA.
Antibodies (Basel) ; 11(1)2022 Mar 02.
Article em En | MEDLINE | ID: mdl-35323192

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Antibodies (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Antibodies (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos